Association of TNF level with production of circulating cellular microparticles during clinical manifestation of human cerebral malaria

Human Immunology

Volumn 74, Issue 6, 2013, Pages 713-721

  Sahu, Upasana ^a   Sahoo, Prakash K ^a   Kar, Shantanu K ^a   Mohapatra, Biranchi N ^b   Ranjit, Manoranjan ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

^b SCB MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BRAIN MALARIA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MACROPHAGE ACTIVATION; MALARIA FALCIPARUM; MALE; MEMBRANE MICROPARTICLE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; HUMANS; MALARIA, CEREBRAL; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84877014666     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.02.006     Document Type: Article

References (45)

1. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
2. Amino R., Thiberge S., Shorte S., Frischknecht F., Ménard R. Quantitative imaging of Plasmodium sporozoites in the mammalian host. C R Biol 2006, 329(11):858-862.
3. Coltel N., Combes V., Hunt N.H., Grau G.E. Cerebral malaria - a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 2004, 1:91-110.
4. Erdman L.K., Finney C.A., Liles W.C., Kain K.C. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol Biochem Parasitol 2008, 162(2):105-111.
5. Schofield L., Grau G.E. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005, 5:722-735.
6. Van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006, 22:503-508.
7. Franklin B.S., Parroche P., Ataide M.A., Lauw F., Ropert C., de Oliveria R.B., et al. Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci USA 2009, 106:5789-5794.
8. Patel S.N., Lu Z., Ayi K., Serghides L., Gowda D.C., Kain K.C. Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J Immunol 2007, 178:3954-3961.
9. Beeson J.G., Brown G.V. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell Mol Life Sci 2002, 59:258-271.
10. Combes V., Coltel N., Alibert M., van Eck M., Raymond C., Juhan-Vague I., et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 2005, 166:295-302.
11. Shet A.S. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008, 4(4):769-774.
12. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009, 101:439-451.
13. Coltel N., Combes V., Wassmer S.C., Chimini G., Grau G.E. Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect 2006, 8:2305-2316.
14. Mitchell P.J., Welton J., Staffurth J., Court J., Mason M.D., Tabi Z., et al. Can urinary exosomes act as treatment response markers in prostate cancer?. J Transl Med 2009, 7:4.
15. Combes V., Taylor T.E., Juhan-Vague I., Mege J.L., Mwenechanya J., Grau G.E., et al. Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. J American Med Assoc 2004, 291:2542-2544.
16. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999, 104(1):93-102.
17. Ranjit M.R. The epidemiology of malaria in Orissa. ICMR Bull 2006, 36:29-38.
18. Hommel M. Essential malariology 2002, 35-58. Arnold International/Oxford Univ. Press, Oxford, UK. 4th ed. D.A. Warrell, H.M. Gillies (Eds.).
19. Metzger W.G., Mordmuller B.G., Kremsner P.G. Malaria pigment in leucocytes. Trans R Soc Trop Med Hyg 1995, 89:637-638.
20. Snounou G., Viriyakosol S., Jarra W., Thaithong S., Brown K.N. Identification of the four human malaria parasite species in field samples by thepolymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 1993, 58:283-292.
21. World Health Organization Communicable diseases cluster: severe falciparum malaria. Trans R Soc Trop Med Hyg 2000, 94(Suppl. 1):S1-S90.
22. Dacie J.V., Lewis S.M. G6PD Assay. Practical Haematology 1991, Churchill Livingstone, Singapore, p. 205-214. 7th ed.
23. Katz N., Coelho P.M.Z., Pellegrino J. Evaluation of Kato's method through the recovery of Schistosoma mansoni eggs added to human feces. J Parasitol 1970, 56:5.
24. Shet A.S., Key N.S., Hebbel R.P. Measuring circulating cell-derived microparticles. J Throm Haemost 2004, 2:1848-1850.
25. Faille D., Combes V., Mitchell A.J., Fontaine A., Juhan-Vague I., Alessi M.C., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J 2009, 1231-1238.
26. Couper K.N., Barnes T., Hafalla J.C.R., Combes V., Ryffel B., Secher T., et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog 2010, 6(1):e1000744.
27. Mfonkeu J.B.P., Gouado I., Kuaté H.F., Zambou O., Zollo P.H.A., Grau G.E., et al. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 2010, 5(10):e13415.
28. Franck P.F.H., Bevers E.M., Lubin B.H., Comfurius P., Chiu D.T., Op den Kamp J.A.F., et al. Uncoupling of the membrane cytoskeleton from the lipid bilayer. J Clin Znuest 1985, 75:183-190.
29. Gallagher P.G., Jarolim P. Red cell membrane disorders. Hematology: basic principles and practice 2005, WB Saunders, Philadelphia. 4th ed.
30. Glushakova S., Yin D., Li T., Zimmerberg J. Membrane transformation during malaria parasite release from human red blood cells. Curr Biol 2005, 15:1645-1650.
31. Moulin F., Lesage F., Legros A.H., Maroga C., Moussavou A., Guyon P. Thrombocytopenia and Plasmodium falciparum malaria in children with different exposures. Arch Dis Child 2003, 88:540-541.
32. Griesshammer M., Bangerter M., Sauer T., Wennauer R., Bergmann L., Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999, 245:295-300.
33. Kwiatkowski D., Hill A., Sambou I., Twumasi P., Castracane J., Manogue K., et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium filaparum malaria. Lancet 1990, 336:1201.
34. Das B.K., Parida S., Ravindran B.A. Prognostic role for anti-phosphatidylcholine antibodies in human cerebral malaria. Clin Exp Immunol 2003, 103:442-445.
35. Karunaweera N.D., Grau G.E., Gamage P., Carter R., Mendis K.N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992, 89:3200-3203.
36. Wassmer S.C., Cianciolo G.J., Combes V., Grau G.E. Inhibition of endothelial activation: a new way to treat cerebral malaria?. PloS Med 2005, 2:e245.
37. Wassmer S.C., Moxon C.A., Taylor T., Grau G.E., Molyneux M.E., Craig A.G. Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell Microbiol 2011, 13:198-209.
38. Andrews R.K., Munday A.D., Mitchell C.A., Berndt M.C. Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Blood 2001, 98(3):681-687.
39. Reininger A.J., Heijnen H.F., Schumann H., Specht H.M., Schramm W., Ruggeri Z.M. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006, 107(9):3537-3545.
40. Wassmer S.C., Lepolard C., Traore B., Pouvelle B., Gysin J., Grau G.E. Platelets reorient Plasmodium falciparum infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis 2004, 189:180-189.
41. Pain A., Urban B.C., Kai O., Casals-Pascual C., Shafi J., Marsh K., et al. A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 2001, 357:1502-1503.
42. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995, 332:1399-1404.
43. Gowda D.C., Davidson E.A. Protein glycosylation in the malaria parasite. Parasitol Today 1999, 15:147-152.
44. Combes V., Coltel N., Faille D., Wassmer S.C., Grau G.E. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int J Parasitol 2006, 36:541-546.
45. Idro R., Jenkins N.E., Newton C.R. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005, 4:827-840.